St. Jude's Biocor acquisition expands tissue heart valve stable.
This article was originally published in The Gray Sheet
Executive Summary
ST. JUDE EUROPEAN SALES FORCE ADDING BIOCOR TISSUE VALVES to its product catalog via the Sept. 23 acquisition of Belo Horizonte, Brazil-based Biocor Industria E Pesquisas Ltd. St. Jude, with a direct sales presence in 14 European countries, plans to switch Biocor's products from existing distributors to its own direct sales force in Europe over the next three to four months.